Lung Cancer - Medscape Lung Cancer : Review in-depth clinical information, latest medical news, and guidelines on lung cancer, specifically small-cell lung cancer and non-small-cell lung cancer Read the latest
Small Cell Lung Cancer in 2024: Treatment Advances - Medscape In 2024 for small cell [lung cancer], there’s a clear benefit of durvalumab in limited-stage disease Tarlatamab is another drug that can provide benefit to our patients, but how to choose
Two Lung Cancer Drugs Recommended by EMA - Medscape Amgen Drug Cuts Small Cell Lung Cancer Death Risk by 40% Updates in Metastatic Non-Small Cell Lung Cancer From ASCO 2025 Small Cell Lung Cancer in 2024: Treatment Advances
A ‘Fool’s Errand’? Picking a Winner for Treating Early NSCLC Is Consolidation Osimertinib Superior to Durvalumab in EGFR-Mutated Non–Small Cell Lung Cancer? Small Cell Lung Cancer in 2024: Treatment Advances 3090D553-9492-4563-8681-AD288FA52ACE
Potential Drivers of LCINS - Medscape During a plenary session at the 2024 World Congress on Lung Cancer, experts addressed the known and suspected causes of LCINS, including fallout from climate change, vaping, cannabis use, and